CHANELLE JACKSON: Open Payments
NPI 1629510862 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,114 in 67 payments from 16 companies in 2025. Trend: 2023 $478 · 2024 $1,018 · 2025 $1,114
Food & beverage: $1,114
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $214 |
| ABBVIE INC. | 15 | $164 |
| Novo Nordisk Inc | 7 | $137 |
| Lilly USA, LLC | 8 | $121 |
| PFIZER INC. | 4 | $78 |
| Abbott Laboratories | 3 | $60 |
| Amgen Inc. | 3 | $58 |
| SHIELD THERAPEUTICS INC | 3 | $50 |
| Dexcom, Inc. | 2 | $41 |
| GlaxoSmithKline, LLC. | 2 | $38 |
Products named: MOUNJARO, AIRSUPRA, Wegovy, QULIPTA, FARXIGA, FREESTYLE LIBRE 3, NURTEC ODT, OTEZLA.
Industry payments across SC — which companies pay providers there.
